Company News
Suzhou Weikangli Biomedical Ltd. was Officially Founded, Focusing on Pharmaceutical Analysis and Quality Control Test of CGT Products
2023-11-08Company News
Strategic Cooperation --- Kanwhish Biotech and Yunjian Medical Signed an Agreement to Jointly Develop Biomarker Analysis and Companion Diagnositics Capabilities
2023-11-08Company News
Strategic Cooperation | Kanwhish Biotech and Tapumed Pharmaceuticals Signed an Agreement to Jointly Support Preclinical Pharmacodynamic Research (Oncology Models Excluded)
2023-11-08Company News
Conference Invitation --- The 13th Cell Industry Conference in November is Approaching as Scheduled, and Kanwhish Biotech is Looking Forward to Meeting you!
2023-11-03Company News
Advanced Instruments | Kanwhish Biotech Released New Generation Cell Sorting System to Support Cost-Efficient Cell Production
2023-09-28Company News
Strategic Cooperation | Kanwhish Biotech and Junjian Biotech Jointly Take an Important Step in mRNA drug R&D and Industrialization
2023-09-18Company News
Conference Review | Kanwhish Biotech Won the "the Bioanalytical CRO with the Most Potential in ADC and BsAb " Award
2023-09-18Company News
Strategic Cooperation | Kanwhish Biotech and XenoFinder Signed an Agreement to Co-Provide DMPK and Bioanalytic Services for ADCs R&D Activities
2023-09-08Company News
Opening Opportunities --- Kanwhish Biotech CRI R&D Center Expands Recruitment!
2023-09-05Academic Exchange
Academic Exchange | Factors and Evaluation Approach for Immunogenicity Risk Assessment
2023-08-31Please tell us your questions or needs
and Kanwhish Biotech will contact you as soon as possible via email or phone.
© 2022 - 2025 CopyrightAll Rights Reserved. ADD:江苏省苏州市吴中区尹山湖路999号C3幢4楼 苏ICP备2023013734号-1
© 2022-2025 Copyright All Rights Reserved. 苏ICP备2023013734号-1